In this event, we will introduce biotech startups with novel technologies and seeds from Kyoto University, Japan. We aim to connect US investors to Japanese academia-oriented startup companies. This will be an excellent opportunity to discover promising startups still in their early stages.

The technologies and seeds in the following fields:

• Pharmaceuticals
• Diagnostics
• Regenerative medicine
• Medical devices

The event schedule:

• 9:00 am Registration
• 10:00 am Showcase presentation
• 12:00 pm Lunch
• 1:00 pm Showcase presentation
• 3:00 pm Reception (Networking)

For details, ask at kurcsd@mail2.adm.kyoto-u.ac.jp.

Presenting companies:

• aceRNA Technologies - Solution provider for new pharmaceutical modalities using RNA switch technology
• Cyfuse Biomedical - Creation of functional tissue with a novel scaffold-free bio 3D printing technology
• Department of Drug Discovery for Lung Diseases, Kyoto University - Innovate the drug discovery for respiratory diseases using iPS-cell technology
• KinoPharma - Innovative therapeutic drug development for cervical intraepithelial neoplasia (CIN) through industry-university collaboration
• Oligogen - Development of drug and cell therapy products using novel human neural stem cells “OligoGenie”
• Quadlytics - Offering epilepsy patients world's first clinically approved seizure prediction software
• Therabiopharma - Development of curcumin monoglucuronide (CMG) as an anticancer drug for phase I/II clinical trials of refractory and rare cancers, glioblastoma and drug-resistant multiple myeloma

Cosponsored by

• Life Science Innovation Network Japan (LINK-J)

Supported by

• Japan Agency for Medical Research and Development (AMED)
• Foundation for Biomedical Research and Innovation at Kobe (FBRI)
• Japan External Trade Organization (JETRO)
• Japan Forum for Innovation and Technology, UCSD (JFIT)
• Japan Science and Technology Agency (JST)
• Science and Innovation for the Next Generation (SING)